MacroGenics, Inc.
MGNX
$1.77
$0.0855.06%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -127.39% | 201.16% | -6.66% | -13.28% | -362.46% |
| Total Depreciation and Amortization | 11.88% | 1.33% | -1.63% | -3.11% | -2.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -551.35% | -3.37% | 30.67% | 42.08% | 107.43% |
| Change in Net Operating Assets | 163.93% | -235.98% | 2,129.53% | -101.17% | 245.65% |
| Cash from Operations | -163.84% | 235.24% | 2.54% | -62.80% | 20.45% |
| Capital Expenditure | -4.73% | 42.80% | 29.06% | -135.32% | -24.25% |
| Sale of Property, Plant, and Equipment | -100.00% | 0.00% | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 16.55% | -25.38% | 84.33% | -33.44% | 219.39% |
| Cash from Investing | 16.48% | -24.96% | 91.32% | -36.13% | 215.80% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,550.00% | -99.05% | -76.09% | 863.14% | 426.92% |
| Repurchase of Common Stock | 94.59% | -1,133.33% | 99.75% | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Financing | 327.94% | -110.88% | 152.02% | -9.16% | -99.45% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -96.64% | 2,575.23% | 117.36% | -286.30% | 158.63% |